Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $1B+, returning 12,168%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,167.96% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,715.02% |
Abivax SA American Depositary Shares (ABVX) | 1,050.97% |
Mobilicom Limited Warrants (MOBBW) | 575.95% |
ThredUp (TDUP) | 563.19% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 546.77% |
TMC the metals (TMC) | 467.54% |
Oklo (OKLO) | 448.8% |
Forward Industries (FORD) | 442.13% |
Nukkleus (NUKKW) | 434.88% |
Opendoor Technologies (OPEN) | 404.62% |
Centrus Energy (LEU) | 367.45% |
Asset Entities Inc Class B Common Stock (ASST) | 360% |
China Yuchai International (CYD) | 346.1% |
IREN (IREN) | 345.49% |
Circle Internet (CRCL) | 331.16% |
MP Materials (MP) | 330.16% |
Nektar Therapeutics (NKTR) | 310.45% |
ATAI Life Sciences (ATAI) | 297.81% |
Celcuity LLC (CELC) | 293.87% |
Amylyx Pharmaceuticals (AMLX) | 293.14% |
Nebius (NBIS) | 291.82% |
Amprius Technologies (AMPX) | 270.49% |
Robinhood Markets (HOOD) | 254.75% |
